TheraCryf Plc

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BSVYN304
GBP
0.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Verici Dx Plc
Niox Group Plc
Kooth Plc
Kanabo Group Plc
Fusion Antibodies Plc
Totally Plc
EDX Medical Group Plc
One Health Group Plc
Cizzle Biotechnology Holdings Plc
TheraCryf Plc
LungLife AI, Inc.
Why is TheraCryf Plc ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is TheraCryf Plc for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
TheraCryf Plc
-60.38%
-0.73
105.18%
FTSE 100
16.5%
1.23
12.99%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
6.58%
EBIT to Interest (avg)
-3.52
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.15
Tax Ratio
6.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.79
EV to EBIT
-0.27
EV to EBITDA
-0.28
EV to Capital Employed
0.31
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-114.56%
ROE (Latest)
-32.52%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at GBP -5.35 MM

ROCE(HY)

Highest at -46.72%

OPERATING PROFIT(Q)

Highest at GBP -0.84 MM

PRE-TAX PROFIT(Q)

Highest at GBP -0.84 MM

NET PROFIT(Q)

Highest at GBP -0.7 MM

EPS(Q)

Highest at GBP -0

-1What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 101.02% (YoY

Here's what is working for TheraCryf Plc
Operating Cash Flow
Highest at GBP -5.35 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (GBP MM)

Operating Profit
Highest at GBP -0.84 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (GBP MM)

Pre-Tax Profit
Highest at GBP -0.84 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (GBP MM)

Pre-Tax Profit
At GBP -0.84 MM has Grown at 60.13%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (GBP MM)

Net Profit
Highest at GBP -0.7 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (GBP MM)

Net Profit
At GBP -0.7 MM has Grown at 58.52%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (GBP MM)

EPS
Highest at GBP -0
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (GBP)

Here's what is not working for TheraCryf Plc
Raw Material Cost
Grown by 101.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales